Mentice Bokslutskommuniké, Jan - Dec 2022
LÄS MER
REGISTRERA DIG FÖR MENTICE BOKSLUTSKOMMUNIKE OKT - DEC 2022 WEBCAST
LÄS MER

David J. Ballard

Board Member
Member of the Audit Committee

Born 1956. M.D., F.A.C.P.,M.S.P.H., Ph.D., M.B.A., trained at the Mayo Clinic following completion of undergraduate degrees in chemistry and economics and graduate degrees in epidemiology (M.S.P.H and Ph.D.) and in medicine from the University of North Carolina. Currently co-founder and Chief Clinical Officer of Concentric Health Alliance. Chief Clinical Advisor M3 Executive Search and several advisory boards. Earlier positions as consultant and founding Head of the Mayo Section of Health Services Evaluation, Professor of Medicine and Epidemiology, Emory University, and Senior Vice President and Chief Quality Officer of Baylor Scott. No other Board assignments.

Holdings

Aktier och optioner

15,905 shares and 238,320 warrants.

Independent

Oberoende

Independent in relation to the Company and its management, and in relation to major shareholders.

Mentice Year-end Report Q4, Oct - Dec 2022
READ MORE
REGISTER
REGISTER FOR THE MENTICE YEAR-END REPORT Q4 OCT - DEC 2022 EARNINGS CALL
READ MORE
REGISTER

David J. Ballard

Board Member
Member of the Audit Committee

Born 1956. M.D., F.A.C.P.,M.S.P.H., Ph.D., M.B.A., trained at the Mayo Clinic following completion of undergraduate degrees in chemistry and economics and graduate degrees in epidemiology (M.S.P.H and Ph.D.) and in medicine from the University of North Carolina. Currently co-founder and Chief Clinical Officer of Concentric Health Alliance. Chief Clinical Advisor M3 Executive Search and several advisory boards. Earlier positions as consultant and founding Head of the Mayo Section of Health Services Evaluation, Professor of Medicine and Epidemiology, Emory University, and Senior Vice President and Chief Quality Officer of Baylor Scott. No other Board assignments.

Holdings

Aktier och optioner

15,905 shares and 238,320 warrants.

Independent

Oberoende

Independent in relation to the Company and its management, and in relation to major shareholders.